Simple subgroup approximations to optimal treatment regimes from randomized clinical trial data

被引:17
|
作者
Foster, Jared C. [1 ,2 ]
Taylor, Jeremy M. G. [1 ]
Kaciroti, Niko [1 ]
Nan, Bin [1 ]
机构
[1] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, Div Intramural Populat Hlth Res, NIH, Rockville, MD 20852 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
Optimal treatment regimes; Personalized medicine; Subgroup analysis; Variable selection; VARIABLE SELECTION; IDENTIFICATION; VALIDATION; MODELS;
D O I
10.1093/biostatistics/kxu049
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We consider the use of randomized clinical trial (RCT) data to identify simple treatment regimes based on some subset of the covariate space, A. The optimal subset, (A) over cap, is selected by maximizing the expected outcome under a treat-if-in-A regime, and is restricted to be a simple, as it is desirable that treatment decisions be made with only a limited amount of patient information required. We consider a two-stage procedure. In stage 1, non-parametric regression is used to estimate treatment effects for each subject, and in stage 2 these treatment effect estimates are used to systematically evaluate many subgroups of a simple, prespecified form to identify (A) over cap. The proposed methods were found to perform favorably compared with two existing methods in simulations, and were applied to prehypertension data from an RCT.
引用
收藏
页码:368 / 382
页数:15
相关论文
共 50 条
  • [21] Comparing brief interventions for suicidal individuals not engaged in treatment: A randomized clinical trial
    Ward-Ciesielski, Erin F.
    Tidik, Julia A.
    Edwards, Amanda J.
    Linehan, Marsha M.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 222 : 153 - 161
  • [22] The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial
    Sharif, Alireza
    Kashani, Hamed Haddad
    Nasri, Elahe
    Soleimani, Zahra
    Sharif, Mohammad Reza
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2017, 9 (04) : 380 - 385
  • [23] Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation
    Bornkamp, Bjoern
    Zaoli, Silvia
    Azzarito, Michela
    Martin, Ruvie
    Mueller, Carsten Philipp
    Moloney, Conor
    Capestro, Giulia
    Ohlssen, David
    Baillie, Mark
    PHARMACEUTICAL STATISTICS, 2024, 23 (04) : 495 - 510
  • [24] Combining Behavioral Weight Loss Treatment and a Commercial Program: A Randomized Clinical Trial
    Pinto, Angela Marinilli
    Fava, Joseph L.
    Hoffmann, Debra A.
    Wing, Rena R.
    OBESITY, 2013, 21 (04) : 673 - 680
  • [25] A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial
    Altstein, Lily L.
    Li, Gang
    Elashoff, Robert M.
    STATISTICS IN MEDICINE, 2011, 30 (07) : 709 - 717
  • [26] Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data
    Bovis, Francesca
    Carmisciano, Luca
    Signori, Alessio
    Pardini, Matteo
    Steinerman, Joshua R.
    Li, Thomas
    Tansy, Aaron P.
    Sormani, Maria Pia
    BMC MEDICINE, 2019, 17 (1)
  • [27] Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results
    Shin, HoJin
    Wang, Shirley V.
    Kim, Dae Hyun
    Alt, Ethan
    Mahesri, Mufaddal
    Bessette, Lily G.
    Schneeweiss, Sebastian
    Najafzadeh, Mehdi
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 853 - 861
  • [28] The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home
    Nordly, Mie
    Benthien, Kirstine Skov
    Von Der Maase, Hans
    Johansen, Christoffer
    Kruse, Marie
    Timm, Helle
    Vadstrup, Eva Soelberg
    Kurita, Geana Paula
    von Heymann-Horan, Annika Berglind
    Sjogren, Per
    BMC PALLIATIVE CARE, 2014, 13
  • [29] Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data
    Francesca Bovis
    Luca Carmisciano
    Alessio Signori
    Matteo Pardini
    Joshua R. Steinerman
    Thomas Li
    Aaron P. Tansy
    Maria Pia Sormani
    BMC Medicine, 17
  • [30] Beyond the Randomized Clinical Trial: Innovative Data Science to Close the Pediatric Evidence Gap
    Goulooze, Sebastiaan
    Zwep, Laura B.
    Vogt, Julia E.
    Krekels, Elke H. J.
    Hankemeier, Thomas
    van den Anker, Johannes N.
    Knibbe, Catherijne A. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 786 - 795